TCL Archive Also Von Eschenbach role in industry program raises new concerns of conflict of interest. November 23, 2005
TCL Archive Also in this 8-page issue: Richard Pazdur named director of FDA’s new Office of Oncology Drug Products. April 22, 2005
TCL Archive NCI Advisors Approve $100M Set Aside for Physical Sciences-Oncology Centers. December 12, 2008